Literature DB >> 8232939

Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease.

F Cardellach1, M J Martí, J Fernández-Solá, C Marín, J B Hoek, E Tolosa, A Urbano-Márquez.   

Abstract

Different abnormalities in mitochondrial electron transport chain activity have been demonstrated in muscle and other tissues of patients with idiopathic Parkinson's disease (PD). We studied eight Spanish patients with PD to evaluate the functional activity of the electron transport chain in muscle mitochondria from patients of this country. We found lower complex I activity (nmol.min-1.mg-1) in patients (245.8 +/- 42.8) than in controls (331.6 +/- 60.1) (p = 0.004) and lower complex IV activity in patients (46.1 +/- 9) than in controls (144.1 +/- 42.3) (p = 0.00001). Complex V activity was also decreased in two patients and complex II and III activities were normal in all of them. Although these results strongly suggest an alteration in mitochondrial DNA in PD, the various electron transport chain defects in different tissues seem to be nonspecific.

Entities:  

Mesh:

Year:  1993        PMID: 8232939     DOI: 10.1212/wnl.43.11.2258

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  Exercise test in Parkinson's disease.

Authors:  I Reuter; M Engelhardt; J Freiwaldt; H Baas
Journal:  Clin Auton Res       Date:  1999-06       Impact factor: 4.435

2.  Human quadriceps muscle mitochondria: a functional characterization.

Authors:  U F Rasmussen; H N Rasmussen
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

Review 3.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

Review 4.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 5.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

6.  Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2.

Authors:  Paul T Kotzbauer; Adam C Truax; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

Review 7.  Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

8.  Complex I function is defective in complex IV-deficient Caenorhabditis elegans.

Authors:  Wichit Suthammarak; Yu-Ying Yang; Phil G Morgan; Margaret M Sedensky
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

Review 9.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

Review 10.  Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease.

Authors:  Laszlo Tretter; Ildiko Sipos; Vera Adam-Vizi
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.